Filing Details
- Accession Number:
- 0001209191-16-135722
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-05 16:59:35
- Reporting Period:
- 2016-08-03
- Filing Date:
- 2016-08-05
- Accepted Time:
- 2016-08-05 16:59:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591313 | R John Desjarlais | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Sr. V.p., Research & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-08-03 | 5,905 | $20.00 | 44,934 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted December 14, 2015.
- Includes 142 shares of Common Stock that were acquired by the Reporting Person on June 10, 2016 pursuant to the Issuer's Employee Stock Purchase Plan.